Many epidemiological studies have shown an association between diets rich i
n carotenoids and a reduced incidence of many forms of cancer, and it has b
een suggested that the antioxidant properties of these compounds are a caus
ative factor. Attention has focused on the potential role of one specific c
arotenoid, beta-carotene, in preventing cancer, and numerous publications h
ave described in vitro experiments and animal studies which suggest that no
t only can this carotenoid protect against the development of cancer, but a
lso several other chronic diseases. Since the immune system plays a major r
ole in cancer prevention, it has been suggested that beta-carotene may enha
nce immune cell function. Several human trials, using dietary beta-carotene
supplementation with a wide range of intakes, have been undertaken to addr
ess this hypothesis. The general conclusion of these studies is that this c
ompound can enhance cell-mediated immune responses, particularly in the eld
erly. The present article will review some of these human studies and, hope
fully, complement the reviews of other authors associated with the present
symposium, some of whom will also describe work in this area. Potential mec
hanisms for the effects of carotenoids on immune function will also be revi
ewed. Finally, possible reasons for the failure of three major prospective
studies to demonstrate a beneficial effect of beta-carotene supplementation
on lung cancer risk will be discussed.